Vascular strategies for enhancing tumour response to radiation therapy

Technology in Cancer Research and Treatment

Volumn 11, Issue 5, 2012, Pages 421-432

  El Kaffas, Ahmed ^a,b   Tran, William ^a   Czarnota, Gregory J ^a,b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti angiogneic agents; Radiation therapy; Tumour vascular imaging; Tumour vasculature; Vascular disrupting agents; Vascular normalization; Vascular targeting agents

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; DNA; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 8; MONOCLONAL ANTIBODY DC101; PERFLUTREN; PLATELET DERIVED GROWTH FACTOR; PROTEIN TYROSINE KINASE INHIBITOR; SUNITINIB; THALIDOMIDE; VADIMEZAN; VANDETANIB; VASCULAR TARGETING AGENT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VATALANIB;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER RADIOTHERAPY; CANCER THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG TARGETING; ENDOTHELIUM CELL; GLIOMA; HUMAN; INTRAVITAL MICROSCOPY; MICRO-COMPUTED TOMOGRAPHY; MICROBUBBLE; MICROENVIRONMENT; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE; RADIOSENSITIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE; TUMOR CELL; ULTRASOUND; X RAY;

EID: 84864371022     PISSN: 15330346     EISSN: None     Source Type: Journal    
DOI: 10.7785/tcrt.2012.500265     Document Type: Article

References (91)

1. Folkman, J. Tumor angiogenesis factor. Cancer Research 34, 2109-2113 (1974).
2. Siemann, D. W. Vascular-targeted therapies in oncology. John Wiley, Chichester (2006).
3. Lehnert, S. Biomolecular action of ionizing radiation. Taylor & Francis, New York (2007).
4. Prise, K. M., Schettino, G., Folkard, M., Held, K. D. New insights on cell death from radiation exposure. The Lancet Oncology 6, 520-528 (2005). DOI: 10.1016/S1470-2045(05)70246-1
5. Qayum, N., Muschel, R. J., Im, J. H., Balathasan, L., Koch, C. J., Patel, S., McKenna, W. G., Bernhard, E. J. Tumor vascular changes mediated by inhibition of oncogenic signaling. Cancer Research 69, 6347-6354 (2009). DOI: 10.1158/0008-5472.CAN-09-0657
6. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., Weichselbaum, R. R. Advances in brief blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Research 59, 3374-3378 (1999).
7. Garcia-Barros, M., Paris, F., Cordon-Cardo, C., Lyden, D., Rafii, S., Haimovitz-Friedman, A., Fuks, Z., Kolesnick, R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300, 1155-1159 (2003). DOI: 10.1126/science.1082504
8. Fuks, Z., Kolesnick, R. Engaging the vascular component of the tumor response. Cancer Cell 8, 89-91 (2005). DOI: 10.1016/j.ccr.2005.07.014
9. Garcia-Barros, M., Lacorazza, D., Petrie, H., Haimovitz-Friedman, A., Cardon-Cardo, C., Nimer, S., Fuks, Z., Kolesnick, R. Host acid sphingomyelinase regulates microvascular function not tumor immunity. Cancer Research 64, 8285-8291 (2004). DOI: 10.1158/0008-5472.CAN-04-2715
10. García-Barros, M., Thin, T. H., Maj, J., Cordon-Cardo, C., Haimovitz-Friedman, A., Fuks, Z., Kolesnick, R. Impact of stromal sensitivity on radiation response of tumors implanted in SCID hosts revisited. Cancer Research 70, 8179-8186 (2010). DOI: 10.1158/0008-5472.CAN-10-1871
11. Carpinteiro, A., Dumitru, C., Schenck, M., Gulbins, E. Ceramide-induced cell death in malignant cells. Cancer Letters 264, 1-10 (2008). DOI: 10.1016/j.canlet.2008.02.020
12. Kolesnick, R. Response to Comments on "Tumor Response to Radiotherapy Regulated by Endothelial Cell Apoptosis. " Science 302, 1894e-1894 (2003). DOI: 10.1126/science.1091166
13. Chometon, G., Jendrossek, V. Targeting the tumour stroma to increase efficacy of chemo-and radiotherapy. Clinical and Translational Oncology 11, 75-81 (2009). DOI: 10.1007/s12094-009-0317-y
14. Paris, F., Fuks, Z., Kang, A., Capodieci, P., Juan, G., Ehleiter, D., Haimovitz-Friedman, A., Cordon-Cardo, C., Kolesnick, R. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 293, 293-297 (2001). DOI: 10.1126/science.1060191
15. Gaugler, M.-H., Neunlist, M., Bonnaud, S., Aubert, P., Benderitter, M., Paris, F. Intestinal epithelial cell dysfunction is mediated by an endothelial-specific radiation-induced bystander effect. Radiation Research 167, 185-193 (2007). DOI: 10.1667/RR0702.1
16. Maj, J. G., Paris, F., Haimovitz-friedman, A. Microvascular Function Regulates Intestinal Crypt Response to Radiation Microvascular Function Regulates Intestinal Crypt Response to Radiation. Cancer Research 4338-4341 (2003).
17. Rotolo, J. A., Mesicek, J., Maj, J., Truman, J.-P., Haimovitz-Friedman, A., Kolesnick, R., Fuks, Z. Regulation of ceramide synthase-mediated crypt epithelium apoptosis by DNA damage repair enzymes. Cancer Research 70, 957-967 (2010). DOI: 10.1158/0008-5472.CAN-09-1562
18. Rotolo, J. A., Kolesnick, R., Fuks, Z. Timing of lethality from gastrointestinal syndrome in mice revisited. International Journal of Radiation Oncology, Biology, Physics 73, 6-8 (2009). DOI: 10.1016/j.ijrobp.2008.09.009
19. Rotolo, J. A., Maj, J. G., Feldman, R., Ren, D., Haimovitz-Friedman, A., Cordon-Cardo, C., Cheng, E. H.-Y., Kolesnick, R., Fuks, Z. Bax and Bak do not exhibit functional redundancy in mediating radiation-induced endothelial apoptosis in the intestinal mucosa. International Journal of Radiation Oncology, Biology, Physics 70, 804-815 (2008). DOI: 10.1016/j.ijrobp.2007.11.043
20. Kirsch, D. G., Santiago, P. M., di Tomaso, E., Sullivan, J. M., Hou, W.-S., Dayton, T., Jeffords, L. B., Sodha, P., Mercer, K. L., Cohen, R., Takeuchi, O., Korsmeyer, S. J., Bronson, R. T., Kim, C. F., Haigis, K. M., Jain, R. K., Jacks, T. P53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis. Science 327, 593-596 (2010). DOI: 10.1126/science.1166202
21. Folkman, J., Camphausen, K. What does radiotherapy do to endothelial cells? Science 293, 227 (2001). DOI: 10.1126/science.1062892
22. Moeller, B. J., Dewhirst, M. W. HIF-1 and tumour radiosensitivity. British Journal of Cancer 95, 1-5 (2006). DOI: 10.1038/sj.bjc.6603201
23. Moeller, B. J., Dreher, M. R., Rabbani, Z. N., Schroeder, T., Cao, Y., Li, C. Y., Dewhirst, M. W. Pleiotropic effects of HIF-1 blockade on tumor radiosensitivity. Cancer Cell 8, 99-110 (2005). DOI: 10.1016/j.ccr.2005.06.016
24. Suit, H. D., Willers, H. Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (I). Science 302, 1894 (2003). DOI: 10.1126/science.1089918
25. Brown, M., Bristow, R., Glazer, P., Hill, R., McBride, W., McKenna, G., Muschel, R. Comment on "Tumor response to radiotherapy regulated by endothelial cell apoptosis" (II). Science 302, 1894 (2003). DOI: 10.1126/science.1089517
26. Budach, W., Gioioso, D., Taghian, A., Stuschke, M., Suit, H. D. Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. International Journal of Radiation Oncology, Biology, Physics 39, 743-750 (1997). DOI: 10.1016/S0360-3016(97)00362-3
27. Gerweck, L. E., Vijayappa, S., Kurimasa, A., Ogawa, K., Chen, D. J. Tumor cell radiosensitivity is a major determinant of tumor response to radiation. Cancer Research 66, 8352-8355 (2006). DOI: 10.1158/0008-5472.CAN-06-0533
28. Ogawa, K., Boucher, Y., Kashiwagi, S., Fukumura, D., Chen, D., Gerweck, L. E. Influence of tumor cell and stroma sensitivity on tumor response to radiation. Cancer Research 67, 4016-4021 (2007). DOI: 10.1158/0008-5472.CAN-06-4498
29. Small, W. Combining targeted biological agents with radiotherapy: current status, and Demos Medical Publishing, New York (2008).
30. Tozer, G. M., Kanthou, C., Baguley, B. C. Disrupting tumour blood vessels. Nature Reviews. Cancer 5, 423-435 (2005). DOI: 10.1038/nrc1628
31. Wachsberger, P., Burd, R., Dicker, A. P. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: exploring mechanisms of interaction. Clinical Cancer Research 9, 1957-1971 (2003).
32. Cooney, M. M., van Heeckeren, W., Bhakta, S., Ortiz, J., Remick, S. C. Drug insight: vascular disrupting agents and angiogenesis--novel approaches for drug delivery. Nature Clinical Practice. Oncology 3, 682-692 (2006). DOI: 10.1038/ncponc0663
33. Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., Weichselbaum, R. R. Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation. Cancer Research 59, 3374-3378 (1999).
34. Cuneo, K. C., Geng, L., Fu, A., Orton, D., Hallahan, D. E., Chakravarthy, A. B. SU11248 (sunitinib) sensitizes pancreatic cancer to the cytotoxic effects of ionizing radiation. Internation Journal of Radiation Oncology, Biology, Physics 71, 873-879 (2008). DOI: 10.1016/j.ijrobp.2008.02.062
35. Yoon, S. S., Stangenberg, L., Lee, Y.-J., Rothrock, C., Dreyfuss, J. M., Baek, K.-H., Waterman, P. R., Nielsen, G. P., Weissleder, R., Mahmood, U., Park, P. J., Jacks, T., Dodd, R. D., Fisher, C. J., Ryeom, S., Kirsch, D. G. Efficacy of sunitinib and radiotherapy in genetically engineered mouse model of soft-tissue sarcoma. Internation Journal of Radiation Oncology, Biology, Physics 74, 1207-1216 (2009). DOI: 10.1016/j.ijrobp.2009.02.052
36. Kamrava, M., Bernstein, M. B., Camphausen, K., Hodge, J. W. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination? Molecular Biosystems 5, 1262-1270 (2009). DOI: 10.1039/b911313b
37. Bergers, G., Hanahan, D. Modes of resistance to anti-angiogenic therapy. Nature reviews. Cancer 8, 592-603 (2008). DOI: 10.1038/nrc2442
38. Gordon, M. S., Mendelson, D. S., Kato, G. Tumor angiogenesis and novel antiangiogenic strategies. International Journal of Cancer. Journal International du Cancer 126, 1777-1787 (2010). DOI: 10.1002/ijc.25026
39. Konno, H., Yamamoto, M., Ohta, M. Recent concepts of antiangiogenic therapy. Surgery Today 40, 494-500 (2010). DOI: 10.1007/s00595-009-4150-2
40. Senan, S., Smit, E. F. Design of clinical trials of radiation combined with antiangiogenic therapy. The Oncologist 12, 465-477 (2007). DOI: 10.1634/theoncologist.12-4-465
41. Boehm, S., Rothermundt, C., Hess, D., Joerger, M. Antiangiogenic drugs in oncology: a focus on drug safety and the elderly-a mini-review. Gerontology 56, 303-309 (2010). DOI: 10.1159/000262450
42. Heath, V. L., Bicknell, R. Anticancer strategies involving the vasculature. Nature Reviews. Clinical Oncology 6, 395-404 (2009). DOI: 10.1038/nrclinonc.2009.52
43. Gupta, N., Nodzenski, E., Khodarev, N. N., Yu, J., Khorasani, L., Beckett, M. A., Kufe, D. W., Weichselbaum, R. R. Angiostatin effects on endothelial cells mediated by ceramide and RhoA. EMBO Reports 2, 536-40 (2001). DOI: 10.1093/embo-reports/kve115
44. Teicher, B. A., Sotomayor, E. A., Huang, Z. D. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Research 52, 6702-6704 (1992).
45. Jain, R. K. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62 (2005). DOI: 10.1126/science.1104819
46. Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., Jain, R. K. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Research 64, 3731-3736 (2004). DOI: 10.1158/0008-5472.CAN-04-0074
47. Fukumura, D., Jain, R. K. Imaging angiogenesis and the microenvironment. APMIS 116, 695-715 (2008). DOI: 10.1111/j.1600-0463.2008.01148.x
48. Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., Munn, L. L., Jain, R. K. Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6, 553-563 (2004). DOI: 10.1016/j.ccr.2004.10.011
49. Kozin, S. V., Boucher, Y., Hicklin, D. J., Bohlen, P., Jain, R. K., Suit, H. D. Vascular Endothelial Growth Factor Receptor-2-blocking Antibody Potentiates Radiation-induced Long-Term Control of Human Tumor Xenografts. Cancer Research 61, 39-44 (2001).
50. McGee, M. C., Hamner, J. B., Williams, R. F., Rosati, S. F., Sims, T. L., Ng, C. Y., Gaber, M. W., Calabrese, C., Wu, J., Nathwani, A. C., Duntsch, C., Merchant, T. E., Davidoff, A. M. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. Internation Journal of Radiation Oncology, Biology, Physics 76, 1537-1545 (2010). DOI: 10.1016/j.ijrobp.2009.12.010
51. Fukumura, D., Jain, R. K. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. Journal of Cellular Biochemistry 101, 937-949 (2007). DOI: 10.1002/jcb.21187
52. Fukumura, D., Jain, R. K. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization. Microvascular Research 74, 72-84 (2007). DOI: 10.1016/j.mvr.2007.05.003
53. Zhou, Q., Guo, P., Gallo, J. M. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14, 1540-9 (2008). DOI: 10.1158/1078-0432.CCR-07-4544
54. Zhou, Q., Gallo, J. M. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model. Neuro-oncology 11, 301-10 (2009). DOI: 10.1215/15228517-2008-088
55. Tozer, G. M., Kanthou, C., Lewis, G., Prise, V. E., Vojnovic, B., Hill, S. A. Tumour vascular disrupting agents: combating treatment resistance. The British Journal of Radiology 81 Spec No, S12-20 (2008). DOI: 10.1259/bjr/36205483
56. Siemann, D. W., Warrington, K. H., Horsman, M. R. Targeting tumor blood vessels: an adjuvant strategy for radiation therapy. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 57, 5-12 (2000). DOI: 10.1016/S0167-8140(00)00243-7
57. Meyer, T. ed. Vascular Disruptive Agents for the Treatment of Cancer (Google eBook). Springer, New York, NY (2010). DOI: 10.1007/978-1-4419-6609-4
58. Needles, A., Goertz, D. E., Karshafian, R., Cherin, E., Brown, A. S., Burns, P. N., Foster, F. S. High-frequency subharmonic pulsed-wave Doppler and color flow imaging of microbubble contrast agents. Ultrasound in Medicine & Biology 34, 1139-1151 (2008). DOI: 10.1016/j.ultrasmedbio.2007.12.011
59. Karshafian, R., Bevan, P. D., Williams, R., Samac, S., Burns, P. N. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound in Medecine and Biology 35, 847-860 (2009). DOI: 10.1016/j.ultrasmedbio.2008.10.013
60. Johnson, C. A., Sarwate, S., Miller, R. J., O'Brien, W. D. A temporal study of ultrasound contrast agent-induced changes in capillary density. Journal of Ultrasound in Medicine 29, 1267-1275 (2010).
61. Haar, G. Safety and bio-effects of ultrasound contrast agents. Medical & Biological Engineering & Computing 47, 893-900 (2009). DOI: 10.1007/s11517-009-0507-3
62. Hassan, M. A., Feril, L. B., Suzuki, K., Kudo, N., Tachibana, K., Kondo, T. Evaluation and comparison of three novel microbubbles: enhancement of ultrasound-induced cell death and free radicals production. Ultrasonics Sonochemistry 16, 372-378 (2009). DOI: 10.1016/j.ultsonch.2008.10.003
63. Kudo, N., Miyaoka, T., Okada, K., Yamamoto, K., Niwa, K. Study on mechanism of cell damage caused by microbubbles exposed to ultrasound. IEEE Ultrasonics Symposium 1383-1386 (2002). DOI: 10.1109/ULTSYM.2002.1192553
64. Wu, J., Nyborg, W. L. Ultrasound, cavitation bubbles and their interaction with cells. Advanced Drug Delivery Reviews 60, 1103-1116 (2008). DOI: 10.1016/j.addr.2008.03.009
65. Mizrahi, N., Seliktar, D., Kimmel, E. Ultrasound-induced angiogenic response in endothelial cells. Ultrasound in Medecine and Biology 33, 1818-1829 (2007). DOI: 10.1016/j.ultrasmedbio.2007.05.007
66. Tran, T. A., Le Guennec, J. Y., Bougnoux, P., Tranquart, F., Bouakaz, A. Characterization of cell membrane response to ultrasound activated microbubbles. IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control 55, 43-49 (2008). DOI: 10.1109/TUFFC.2008.615
67. Collis, J., Manasseh, R., Liovic, P., Tho, P., Ooi, A., Petkovic-Duran, K., Zhu, Y. Cavitation microstreaming and stress fields created by microbubbles. Ultrasonics 50, 273-279 (2010). DOI: 10.1016/j.ultras.2009.10.002
68. Berbeco, R. I., Ngwa, W., Makrigiorgos, G. M. Localized Dose Enhancement to Tumor Blood Vessel Endothelial Cells via Megavoltage X-rays and Targeted Gold Nanoparticles: New Potential for External Beam Radiotherapy. International Journal of Radiation Oncology, Biology and Physics 81, 270-276 (2010). DOI: 10.1016/j.ijrobp.2010.10.022
69. Ngwa, W., Makrigiorgos, G. M., Berbeco, R. I. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Physics in Medicine and Biology 55, 6533-6548 (2010). DOI: 10.1088/0031-9155/55/21/013
70. Ngwa, W., Makrigiorgos, G. M., Berbeco, R. I. Gold nanoparticle-aided brachytherapy with vascular dose painting: Estimation of dose enhancement to the tumor endothelial cell nucleus. Medical Physics 39, 392 (2012). DOI: 10.1118/1.3671905
71. Turkbey, B., Kobayashi, H., Ogawa, M., Bernardo, M., Choyke, P. L. Imaging of tumor angiogenesis: functional or targeted? AJR. American Journal of Roentgenology 193, 304-313 (2009). DOI: 10.2214/AJR.09.2869
72. Fukumura, D., Jain, R. K. Imaging angiogenesis and the microenvironment. APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica 116, 695-715 (2008). DOI: 10.1111/j.1600-0463.2008.01148.x
73. Vakoc, B. J., Lanning, R. M., Tyrrell, J. A., Padera, T. P., Bartlett, L. A., Stylianopoulos, T., Munn, L. L., Tearney, G. J., Fukumura, D., Jain, R. K., Bouma, B. E. Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging. Nature Medicine 15, 1219-1223 (2009). DOI: 10.1038/nm.1971
74. Mariampillai, A., Standish, B. A., Moriyama, E. H., Khurana, M., Munce, N. R., Leung, M. K., Jiang, J., Cable, A., Wilson, B. C., Vitkin, I. A., Yang, V. X. D. Speckle variance detection of microvasculature using swept-source optical coherence tomography. Optics Letters 33, 1530-1532 (2008). DOI: 10.1364/OL.33.001530
75. Goertz, D. E., Yu, J. L., Kerbel, R. S., Burns, P. N., Foster, F. S. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Research 62, 6371-6375 (2002).
76. Hoskins, P. R., Wells, P. N. T. Haemodynamics and blood flow measured using ultrasound imaging. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 224, 255-271 (2010). DOI: 10.1243/09544119JEIM572
77. Sboros, V., Tang, M.-X., Wells, P. N. T. The assessment of microvascular flow and tissue perfusion using ultrasound imaging. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 224, 273-290 (2010). DOI: 10.1243/09544119JEIM621
78. Sboros, V., Tang, M.-X., Wells, P. N. T. The assessment of microvascular flow and tissue perfusion using ultrasound imaging. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 224, 273-290 (2010). DOI: 10.1243/09544119JEIM621
79. Su, J.-M., Huang, Y.-F., Chen, H. H. W., Cheng, Y.-M., Chou, C.-Y. Three-dimensional power doppler ultrasound is useful to monitor the response to treatment in a patient with primary papillary serous carcinoma of the peritoneum. Ultrasound in Medicine and Biology 32, 623-626 (2006). DOI: 10.1016/j.ultrasmedbio.2006.01.005
80. Foster, F. S., Burns, P. N., Simpson, D. H., Wilson, S. R., Christopher, D. A., Goertz, D. E. Ultrasound for the visualization and quantification of tumor microcirculation. Cancer Metastasis Review 19, 131-138 (2000).
81. Gee, M. S., Saunders, H. M., Lee, J. C., Sanzo, J. F., Jenkins, W. T., Evans, S. M., Trinchieri, G., Sehgal, C. M., Feldman, M. D., Lee, W. M. Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Research 61, 2974-2982 (2001).
82. Rubin, J. M., Bude, R. O., Fowlkes, J. B., Spratt, R. S., Carson, P. L., Adler, R. S. Normalizing fractional moving blood volume estimates with power Doppler US: defining a stable intravascular point with the cumulative power distribution function. Radiology 205, 757-765 (1997).
83. Galván, R., Mercé, L., Jurado, M., Mínguez, J. A., López-García, G., Alcázar, J. L. Three-dimensional power Doppler angiography in endometrial cancer: correlation with tumor characteristics. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 35, 723-729 (2010). DOI: 10.1002/uog.7633
84. Stride, E. P., Coussios, C. C., Wells, P. N. T. Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy. Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine 224, 171-191 (2010). DOI: 10.1243/09544119JEIM622
85. Hwang, M., Hariri, G., Lyshchik, A., Hallahan, D. E., Fleischer, A. C. Correlation of quantified contrast-enhanced sonography with in vivo tumor response. Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 29, 597-607 (2010).
86. Jennings, D., Raghunand, N., Gillies, R. J. Imaging hemodynamics. Cancer Metastasis Review 27, 589-613 (2008). DOI: 10.1007/s10555-008-9157-4
87. Sorensen, A. G., Batchelor, T. T., Zhang, W.-T., Chen, P.-J., Yeo, P., Wang, M., Jennings, D., Wen, P. Y., Lahdenranta, J., Ancukiewicz, M., di Tomaso, E., Duda, D. G., Jain, R. K. A "vascular normalization index" as potential mechanistic biomarker to predict survival after a single dose of cediranib in recurrent glioblastoma patients. Cancer Research 69, 5296-5300 (2009). DOI: 10.1158/0008-5472.CAN-09-0814
88. Nguyen, V., Gaber, M. W., Sontag, M. R., Kiani, M. F. Late effects of ionizing radiation on the microvascular networks in normal tissue. Radiation Research 154, 531-536 (2000). DOI: 10.1667/0033-7587(2000)154[0531:LEOIRO]2.0.CO;2
89. Baker, D. G., Krochak, R. J. The response of the microvascular system to radiation: a review. Cancer Investigation 7, 287-294 (1989). DOI: 10.3109/07357908909039849
90. Dimitrievich, G. S., Hausladen, S. L., Kuchnir, F. T., Griem, M. I. Radiation Damage and Subendothelial Repair to Rabbit Ear Chamber Microvasculature. Radiation Research 69, 276-292 (2010).
91. Ahmad, M., Khurana, N. R., Jaberi, J. E. Ionizing radiation decreases capillary-like structure formation by endothelial cells in vitro. Microvascular Research 73, 14-19 (2007).